Perspectives on Cognitive EnhancementIn a recent article in the prestigious scientific journal,
Nature, Hank Greely, professor of law at Stanford University,
and colleagues called for "a presumption that mentally
competent adults should be able to engage in cognitive enhancement
using drugs." Greely discussed their conclusions at a presentation
for the Ethics Center May 7. A leading expert on the legal,
ethical, and social issues surrounding health law and the biosciences,
Greely specializes in the implications of new biomedical technologies.
He is a co-director of the MacArthur Foundation Project on Law
and Neuroscience and chairs the steering committee for the Stanford
Center for Biomedical Ethics. In addition, he directs both the
law schools Center for Law and the Biosciences and the
Stanford Center for Biomedical Ethics Program in Neuroethics. The Centers Emerging Issues Group took up the same topic
at their weekly meeting May 11. Present at the discussion were
Center Bioethics Director Margaret R. McLean; science reporter
Sally Lehrman, the Knight Ridder/San Jose Mercury News Professor
of Journalism in the Public Interest at SCU; Visiting Fellow
J. Brooke Hamilton, associate professor of management at University
of Louisiana-Lafayette and chair of the Ethics Committee and
Institutional Review Board of the University Medical Center;
and Kirk O. Hanson, executive director of the Markkula Center
for Applied Ethics. Center Communications Director Miriam Schulman
was moderator. |
New Materials
- Ethical Responsibilities of Hospital Trustees
Presentation to the Governance Conference of Premier Inc. - Ethics and Venture Capital
Reflections by Asset Management Co-Founder "Pitch" Johnson - Effective Boards (video)
A conversation on corporate governance - Conscience, Catholicism, and American Politics
Reflections by Bishop Robert McElroy - Too Close for Comfort? (case)
Conflicts of Interest at a Non-Profit
Center News
-
Why You Treat Me So Bad?
A poetry slam on love gone wrong, Feb. 13. - Adderall and Ethics
Center's Big Q project looks at study drugs


